Pleuropulmonary infections caused by Mycobacterium bovis: A re-emerging disease

Clinical Microbiology and Infection

Volumn 11, Issue 10, 2005, Pages 840-843

  Esteban, J ^a   Robles, P ^a   Soledad Jimenez M ^b   Fernandez Guerrero M L ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Human immunodeficiency virus; Multidrug resistance; Mycobacterium bovis; Pleuropulmonary disease; Therapy; Tuberculosis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ETHAMBUTOL; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; PRIORITY JOURNAL; SPAIN;

HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM BOVIS;

EID: 25144480962     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01225.x     Document Type: Article

References (19)

1. Wayne LG, Kubica GP. Genus Mycobacterium. In: Sneath PHA, Mair NS, Sharpe ME, Holt JG, eds. Bergey's manual of systematic bacteriology. Baltimore: Williams & Wilkins, 1986; 1436-1457.
2. Bouvet E, Casalino E, Mendoza Sassi G et al. A nosocomial outbreak of multidrug-resistant Mycobacterium bovis among HIV-infected patients. A case-control study. Aids 1993; 7: 1453-1460.
3. Gutierrez MC, Bouvet E, Blazquez J, Vincent V. Identification as Mycobacterium tuberculosis of previously described M. bovis multidrug-resistant strains. Lancet 1998; 351: 758.
4. Dankner WM, Waecker NJ, Essey MA, Moser K, Thompson M, Davis CE. Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine (Baltimore) 1993; 72: 11-37.
5. Schultsz C, Kuijper EJ, van Soolingen D, Prins JM. Disseminated infection due to multidrug-resistant Mycobacterium bovis in a patient who was seropositive for human immunodeficiency virus. Clin Infect Dis 1996; 23: 841-843.
6. Palenque E, Villena V, Rebollo MJ, Jimenez MS, Samper S. Transmission of multidrug-resistant Mycobacterium bovis to an immunocompetent patient. Clin Infect Dis 1998; 26: 995-996.
7. Guerrero A, Cobo J, Fortun J et al. Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection. Lancet 1997; 350: 1738-1742.
8. Blazquez J, Espinosa de los Monteros LE, Samper S et al. Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients. J Clin Microbiol 1997; 35: 1390-1393.
9. Gori A, Marchetti G, Catozzi L et al. Molecular epidemiology characterization of a multidrug-resistant Mycobacterium bovis outbreak amongst HIV-positive patients. AIDS 1998; 12: 445-446.
10. Rivero A, Marquez M, Santos J et al. High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B. Clin Infect Dis 2001; 32: 159-161.
11. Metchock BG, Nolte FS, Wallace RJ. Mycobacterium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology, 7th edn. Washington, DC: ASM Press, 1999; 399-437.
12. Samper S, Iglesias MJ, Tello O. The Spanish multidrug resistant tuberculosis network. Eurosurveillance 2000; 5: 43-45.
13. Samper S, Martin C, Pinedo A et al. Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis. AIDS 1997; 11: 1237-1242.
14. Haas DW, Des Prez RM. Mycobacterium tuberculosis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 4th edn. New York: Churchill Livingstone, 1995; 2213-2243.
15. American Thoracic Society, Centers for Diseases Control, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR 2003; 52: 1-80.
16. Snider DE, Raviglione M, Kochi A. Global burden of tuberculosis. In: Bloom BR, ed. Tuberculosis: pathogenesis, protection and control. Washington, DC: ASM Press, 1994; 3-11.
17. Robles P, Esteban J, Fernández-Guerrero ML. Pulmonary tuberculosis due to multidrug-resistant Mycobacterium bovis in a healthy host. Clin Infect Dis 2002; 35: 212.
18. Smith RM, Drobniewski F, Gibson A et al. Mycobacterium bovis infection, United Kingdom. Emerg Infect Dis 2004; 10: 539-541.
19. Esteban J, Granizo JJ, Álvarez-Castillo MC, Soriano F. Drug resistance among Mycobacterium tuberculosis strains in immigrants: is there a real threat everywhere? Clin Microbiol Infect 2004; 10: 335-336.